Patients with moderate tricuspid regurgitation (TR) undergoing surgery for mitral valve disease have a significant improvement in TR grade, according to the results of a new study. In early ...

LONDON, England—All going to plan, the next few years should deliver some concrete results for transcatheter devices being tested for tricuspid regurgitation (TR). In the meantime, experts working in ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHOENIX -- ...

Using the Mitralign Percutaneous Annuloplasty System to repair a mitral valve--Screenshot courtesy of Mitralign Mitralign has raised $39.8 million in a Series E round to help it get U.S. and EU ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Addressing ...

Edwards Lifesciences announced an agreement to acquire Valtech Cardio Ltd., maker of a system for transcatheter repair of mitral and tricuspid valves, for $340 million plus potential milestone ...

While previous trials have led to questions surrounding the potential benefits of valve interventions in mitral or tricuspid regurgitation, a pair of trials presented recently demonstrate their ...

An international study of more than 400 adults concludes that people who undergo mitral valve surgery (between the left atrium and the left ventricle of the heart) and also have less than severe ...

Patients with mitral and tricuspid valve regurgitation, a condition sometimes called "leaky heart valves," appeared to do better after two years if they had a tricuspid valve repair at the time of ...

Delirium occurred in nearly 1-in-10 elderly patients after percutaneous mitral and tricuspid valve repair and signaled longer hospital stays and worse survival, a new study shows. Mortality was nearly ...

Edwards Lifesciences (NYSE: EW) and Boston Scientific (NYSE: BSX) both reported strong quarters, but the results reveal ...

An estimated 1.6 million Americans suffer moderate to severe leakage through their heart's tricuspid valve, but what causes the problem is not well understood. A new study found that either dilating ...